WASHINGTON–LAWFUEL – The Law Firm Newswire – Hunton & Williams LLP announced today that Sheldon Bradshaw, Chief Counsel of the United States Food & Drug Administration, will join the firm as a partner and co-chair of the firm’s Food and Drug Practice. Bradshaw publicly announced his resignation from his current position with the FDA today and will join Hunton & Williams’ Washington office in October.
“We have been looking to expand our Food and Drug Practice and Sheldon is an exceptional addition to our existing team,” said Wally Martinez, managing partner of Hunton & Williams. “He brings a wealth of experience from both the FDA and the Department of Justice which will be invaluable to our clients not only served by the Food and Drug Practice, but many of our other practices, as well.”
Bradshaw served as Chief Counsel of the FDA since 2005, where he was responsible for providing legal advice to senior leadership at the FDA and the Department of Health and Human Services; and for managing the work of more than 100 lawyers and staff. During his tenure, he oversaw controversial regulatory issues dealing with drugs, biologics, medical devices, food, and other products. He also reviewed and approved every regulation, guidance and warning letter issued by FDA; oversaw all FDA-related litigation; and negotiated and drafted landmark legislation expected to be enacted this year.
“Sheldon’s experience as Chief Counsel at FDA and his understanding of how the agency makes decisions will bring immediate benefits to the firm’s existing clients,” said Gary Messplay, who is chair of Hunton & Williams’ Food and Drug Practice and will co-chair the practice group with Bradshaw upon his arrival.
Hunton & Williams’ Food and Drug Practice, based in Washington, provides legal and regulatory assistance to both emerging companies and large multinational corporations. It is a full-service food and drug practice covering all product categories, and involves regulatory and compliance counseling, government relations issues, transactions, and litigation and enforcement. The group assists clients in obtaining FDA approval of new products and developing regulatory approval strategies, clinical trial development and design, product labeling, and manufacturing issues.
“Hunton & Williams’ Food and Drug Practice is extremely well-respected in the biologics, pharma and related industry circles in the United States and internationally,” said Bradshaw. “This is a vibrant, stand-out practice in a very specialized area of law that presented a natural fit for my experience and future professional growth. I look forward to returning to private practice and helping to advance Hunton & Williams’ Food and Drug Practice at a time when this area of law is growing exponentially in response to the rapid pace of related industry growth and development worldwide.”
Bradshaw began his legal career as a law clerk for Chief Judge Karen J. Williams of the United States Court of Appeals for the Fourth Circuit, and he worked as an associate with Howrey Simon Arnold & White, LLP from 1999-2001.
He left private practice in 2001 when he was appointed Deputy Assistant Attorney General for the Office of Legal Counsel at the U.S. Department of Justice. There he provided legal advice to the White House, the Attorney General, and federal agencies on a variety of constitutional, statutory, and regulatory matters. In addition, prior to joining the FDA in 2005, Bradshaw served as the Principal Deputy Assistant Attorney General for the Civil Rights Division at the Department of Justice.
Bradshaw received his law degree with honors from The George Washington University School of Law in 1996, and his bachelor’s degree from Brigham Young University in 1991.
About Hunton & Williams LLP
Hunton & Williams LLP provides legal services to corporations, financial institutions, governments and individuals, as well as to a broad array of other entities. Since our establishment more than a century ago, Hunton & Williams has grown to more than 975 attorneys serving clients in 100 countries from 19 offices around the world. While our practice has a strong industry focus on energy, financial services and life sciences, the depth and breadth of our experience extends to more than 100 separate practice areas, including bankruptcy and creditors rights, commercial litigation, corporate transactions and securities law, competition law, FDA, intellectual property, international and government relations, regulatory law, products liability, and privacy and information management.
For more information about Hunton & Williams, visit our website at www.hunton.com.
